Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CD4 CELL COUNT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 71 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Skowron, G; Street, JC; Obee, EM
      Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Gerna, G; Piccinini, G; Genini, E; Percivalle, E; Zavattoni, M; Lilleri, D; Testa, L; Comolli, G; Maserati, T; Baldanti, F; Maccario, R; Monforte, AD; Revello, MG
      Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Brambilla, AM; Castagna, A; Nocita, B; Hasson, H; Boeri, E; Veglia, F; Lazzarin, A
      Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Girardi, E; Palmieri, F; Cingolani, A; Ammassari, A; Petrosillo, N; Gillini, L; Zinzi, D; De Luca, A; Antinori, A; Ippolito, G
      Changing clinical presentation and survival in HIV-associated tuberculosisafter highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Becker, SL; Raffanti, SR; Hansen, NI; Fusco, JS; Fusco, GP; Slatko, GH; Igboko, EF; Graham, NMH
      Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Mijch, AM; Hoy, J; Watson, K; Dunne, A; Crowe, S; Wesselingh, SL
      Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?

      JOURNAL OF CLINICAL VIROLOGY
    7. Cobo, J; Asensio, A; Moreno, S; Navas, E; Pintado, V; Oliva, J; Gomez-Mampaso, E; Guerrero, A
      Risk factors for nosocomial transmission of multidrug-resistant tuberculosis due to Mycobacterium bovis among HIV-infected patients

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    8. Rey, D; Schmitt, MP; Hess-Kempf, G; Krantz, V; Partisani, M; Bernard-Henry, C; Lang, JM
      Structured therapeutic interruption (STI) in HIV-1 infected patients with virological failure: preliminary results.

      PATHOLOGIE BIOLOGIE
    9. Lepri, AC; Phillips, AN; Monforte, AD; Castelli, F; Antinori, A; de Luca, A; Pezzotti, P; Alberici, F; Cargnel, A; Grima, P; Piscopo, R; Prestileo, T; Scalise, G; Vigevani, M; Moroni, M
      When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study

      AIDS
    10. Furrer, H; Opravil, M; Rossi, M; Bernasconi, E; Telenti, A; Bucher, H; Schiffer, V; Boggian, K; Rickenbach, M; Flepp, M; Egger, M
      Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study

      AIDS
    11. Cohen, RA; Boland, R; Paul, R; Tashima, KT; Schoenbaum, EE; Celentano, DD; Schuman, P; Smith, DK; Carpenter, CCJ
      Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women

      AIDS
    12. Grant, LA; Silverberg, MJ; Palacio, H; Minkoff, H; Anastos, K; Young, MA; Nowicki, M; Kovacs, A; Cohen, M; Munoz, A
      Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels

      AIDS
    13. Gross, R; Bilker, WB; Friedman, HM; Strom, BL
      Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

      AIDS
    14. Lucas, GM; Chaisson, RE; Moore, RD
      Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz

      AIDS
    15. Samet, JH; Freedberg, KA; Savetsky, JB; Sullivan, LM; Stein, MD
      Understanding delay to medical care for HIV infection: the long-term non-presenter

      AIDS
    16. Gilbert, PB; DeGruttola, V; Hammer, SM; Kuritzkes, DR
      Virologic and regimen termination surrogate end points in AIDS clinical trials

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    17. Bongertz, V
      Vertical human immunodeficiency virus type 1 - HIV-1 - Transmission - A review

      MEMORIAS DO INSTITUTO OSWALDO CRUZ
    18. Minkoff, H; Ahdieh, L; Watts, H; Greenblatt, RM; Schmidt, J; Schneider, M; Stek, A
      The relationship of pregnancy to the use of highly active antiretroviral therapy

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    19. Anastos, K; Gange, SJ; Lau, B; Weiser, B; Detels, R; Giorgi, JV; Margolick, JB; Cohen, M; Phair, J; Melnick, S; Rinaldo, CR; Kovacs, A; Levine, A; Landesman, S; Young, M; Munoz, A; Greenblatt, RM
      Association of race and gender with HIV-1 RNA levels and immunologic progression

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    20. Masel, J; Arnaout, RA; O'Brien, TR; Goedert, JJ; Lloyd, AL
      Fluctuations in HIV-1 viral load are correlated to CD4(+) T-lymphocyte count during the natural course of infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    21. Sabin, CA; Devereux, H; Phillips, AN; Hill, A; Janossy, G; Lee, CA; Loveday, C
      Course of viral load throughout HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    22. Re, MC; Ramazzotti, E; Manfredi, R; Furlini, G; Vignoli, M; Maldini, C; Borderi, M; La Placa, M
      Viral load trend in HIV-1 seropositive patients with different CD4 cell counts before starting HAART

      JOURNAL OF CLINICAL VIROLOGY
    23. Margiotta, V; Campisi, G; Mancuso, S
      Plasma HIV-1 RNA and route of transmission in oral candidiasis and oral hairy leukoplakia

      ORAL DISEASES
    24. Coakley, EPG; Samore, MH; Gillis, JM; Hughes, MD; Hammer, SM
      The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of <= 50 x 10(6) cells/l

      AIDS
    25. Maas, JJJ; Gange, SJ; Schuitemaker, H; Coutinho, RA; van Leeuwen, R; Margolick, JB
      Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study

      AIDS
    26. Gupta, SB; Gilbert, RL; Brady, AR; Livingstone, SJ; Evans, BG
      CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990-1998

      AIDS
    27. Eron, JJ; Yetzer, ES; Ruane, PJ; Becker, S; Sawyerr, GA; Fisher, RL; Tolson, JM; Shaefer, MS
      Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

      AIDS
    28. Angel, JB; High, K; Rhame, F; Brand, D; Whitmore, JB; Agosti, JM; Gilbert, MJ; Deresinski, S
      Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression

      AIDS
    29. O'Donovan, D; Ariyoshi, K; Milligan, P; Ota, M; Yamuah, L; Sarge-Njie, R; Whittle, H
      Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia

      AIDS
    30. Garcia, F; Knobel, H; Sambeat, MA; Arrizabalaga, J; Aranda, M; Romeu, J; Dalmau, D; Segura, F; Gomez-Sirvent, JL; Ferrer, E; Cruceta, A; Gallart, T; Pumarola, T; Miro, JM; Gatell, JM
      Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study

      AIDS
    31. Angel, JB; Jacobson, MA; Skolnik, PR; Giordano, M; Shapiro, L; LeBeaut, A; Greaves, W; Fuchs, AC
      A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects

      AIDS
    32. Embree, JE; Njenga, S; Datta, P; Nagelkerke, NJD; Ndinya-Achola, JO; Mohammed, Z; Ramdahin, S; Bwayo, JJ; Plummer, FA
      Risk factors for postnatal mother-child transmission of HIV-1

      AIDS
    33. Wood, E; Yip, B; Hogg, RS; Sherlock, CH; Jahnke, N; Harrigan, RP; O'Shaughnessy, MV; Montaner, JSG
      Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

      AIDS
    34. Prins, M; Sabin, CA; Lee, CA; Devereux, H; Coutinho, RA
      Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men

      AIDS
    35. Reiss, P; Vella, S; Cooper, D; Lange, J; Gartland, M; Gerstoft, J; Goebel, F; Larder, B; Clumeck, N; Gatell, J; Gazzard, B; Rozenbaum, W; Rae, S; O'Shaughnessy, MV; Robinson, P; Harrigan, PR; Raboud, J; Alexander, CS; Maguire, M; Montaner, JS
      Highly active antiretroviral therapy including protease inhibitors does not confer a unique CD4 cell benefit

      AIDS
    36. Furrer, H; Telenti, A; Rossi, M; Ledergerber, B
      Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study

      AIDS
    37. Helbert, M; Breuer, J
      Monitoring patients with HIV disease

      JOURNAL OF CLINICAL PATHOLOGY
    38. Paredes, R; Mocroft, A; Kirk, O; Lazzarin, A; Barton, SE; van Lunzen, J; Katzenstein, TL; Antunes, F; Lundgren, JD; Clotet, B
      Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe - Results fromthe EuroSIDA Study

      ARCHIVES OF INTERNAL MEDICINE
    39. Jensen, BL; Weismann, K; Sindrup, JH; Sondergaard, J; Schmidt, K
      Incidence and prognostic significance of skin disease in patients with HIV/AIDS: A 5-year observational study

      ACTA DERMATO-VENEREOLOGICA
    40. Williams, PL; Currier, JS; Swindells, S
      Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections

      AIDS
    41. Aboulker, JP; Babiker, AG; Flandre, P; Gazzard, B; Loveday, C; Nunn, AJ; Goudsmit, J; Huraux, JM; van der Noorda, J; Weiss, R; Boucher, C; Schurrman, R; Brun-Vezinet, F; Descamps, D; Jeffries, D; Tedder, R; Weber, J; Darbyshire, JH; Reiss, P; Weverling, G
      An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome

      AIDS
    42. Garcia, F; Romeu, J; Grau, I; Sambeat, MA; Dalmau, D; Knobel, H; Gomez-Sirvent, JL; Arrizabalaga, J; Cruceta, A; Clotet, B; Podzamczer, D; Pumarola, T; Gallart, T; O'Brien, WA; Miro, JM; Gatell, JM
      A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study

      AIDS
    43. Monforte, AD; Testori, V; Adorni, F; Castelnuovo, B; Bini, T; Testa, L; Moscatelli, G; Chiesa, E; Rusconi, S; Abeli, C; Sollima, S; Musicco, M; Meroni, L; Galli, M; Moroni, M
      CD4 cell counts at the third month of HAART may predict clinical failure

      AIDS
    44. Anastos, K; Kalish, LA; Hessol, N; Weiser, B; Melnick, S; Burns, D; Delapenha, R; DeHovitz, J; Cohen, M; Meyer, W; Bremer, J; Kovacs, A
      The relative value od CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study

      AIDS
    45. Mocroft, A; Barry, S; Sabin, CA; Lepri, AC; Kinloch, S; Drinkwater, A; Lipman, M; Youle, M; Johnson, MA; Phillips, AN
      The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997

      AIDS
    46. Kelleher, T; Cross, A; Dunkle, L
      Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine

      CLINICAL THERAPEUTICS
    47. Arnaout, RA; Lloyd, AL; O'Brien, TR; Goedert, JJ; Leonard, JM; Nowak, MA
      A simple relationship between viral load and survival time in HIV-1 infection

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    48. SHEN MC; HU FC; LIN JS; HSIE SW; HUNG CC; CHUNG CY
      HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN HEMOPHILIACS IN TAIWAN - THE IMPORTANCE OF CD4 LYMPHOCYTE COUNT IN THE PROGRESSION TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME

      Haemophilia
    49. SHEN MC; HU FC; LIN JS; TSAI W; FON MF; WANG EC
      A LONGITUDINAL-STUDY OF IMMUNOLOGICAL STATUS IN CHINESE HEMOPHILIACS - IMPORTANCE OF THE HEAT VIRAL INACTIVATION OF FACTOR CONCENTRATES - II - IMPROVEMENTS OF CD4 CD8 RATIO AFTER TREATMENTS WITH HEAT-INACTIVATED FACTOR CONCENTRATES/

      Haemophilia
    50. SAVIOZ D; CHILCOTT M; LUDWIG C; SAVIOZ M; KAISER L; LEISSING C; BUHLER L; PETER R; MOREL P
      PREOPERATIVE COUNTS OF CD4 T-LYMPHOCYTES AND EARLY POSTOPERATIVE INFECTIVE COMPLICATIONS IN HIV-POSITIVE PATIENTS

      The European journal of surgery
    51. VANDERRYST E; KOTZE M; JOUBERT G; STEYN M; PIETERS H; VANDERWESTHUIZEN M; VANSTADEN M; VENTER C
      CORRELATION AMONG TOTAL LYMPHOCYTE COUNT, ABSOLUTE CD4(-1-INFECTED SOUTH-AFRICAN PATIENTS() COUNT, AND CD4(+) PERCENTAGE IN A GROUP OF HIV)

      Journal of acquired immune deficiency syndromes and human retrovirology
    52. SABIN CA; MOCROFT A; LEPRI AC; PHILLIPS AN
      COFACTORS AND MARKERS OF DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Journal of the Royal Statistical Society. Series A. Statistics in society
    53. MONTANER JSG; DEMASI R; HILL AM
      THE EFFECTS OF LAMIVUDINE TREATMENT ON HIV-1 DISEASE PROGRESSION ARE HIGHLY CORRELATED WITH PLASMA HIV-1 RNA AND CD4 CELL COUNT

      AIDS
    54. ROOS MTL; PRINS M; KOOT M; DEWOLF F; BAKKER M; COUTINHO RA; MIEDEMA F; SCHELLEKENS PTA
      LOW T-CELL RESPONSES TO CD3 PLUS CD28 MONOCLONAL-ANTIBODIES ARE PREDICTIVE OF DEVELOPMENT OF AIDS

      AIDS
    55. HUGHES MD; DANIELS MJ; FISCHL MA; KIM S; SCHOOLEY RT
      CD4 CELL COUNT AS A SURROGATE END-POINT IN HIV CLINICAL-TRIALS - A METAANALYSIS OF STUDIES OF THE AIDS CLINICAL-TRIALS GROUP

      AIDS
    56. SABIN CA; DEVEREUX H; PHILLIPS AN; JANOSSY G; LOVEDAY C; LEE CA
      IMMUNE MARKERS AND VIRAL LOAD AFTER HIV-1 SEROCONVERSION AS PREDICTORS OF DISEASE PROGRESSION IN A COHORT OF HEMOPHILIC MEN

      AIDS
    57. Bycott, PW; Taylor, JMG
      An evaluation of a measure of the proportion of the treatment effect explained by a surrogate marker

      CONTROLLED CLINICAL TRIALS
    58. KUPFER B; KAISER R; ROCKSTROH JK; MATZ B; SCHNEWEIS KE
      ROLE OF HIV-1 PHENOTYPE IN VIRAL PATHOGENESIS AND ITS RELATION TO VIRAL LOAD AND CD4-CELL COUNT( T)

      Journal of medical virology
    59. SABIN CA; MOCROFT A; BOFILL M; JANOSSY G; JOHNSON M; LEE CA; PHILLIPS AN
      SURVIVAL AFTER A VERY-LOW (LESS-THAN-5X10(6) L) CD4+ T-CELL COUNT IN INDIVIDUALS INFECTED WITH HIV/

      AIDS
    60. CHENE G; EASTERBROOK PJ; JUSZCZAK E; YU LM; POCOCK SJ; GAZZARD BG
      LONG-TERM SURVIVAL IN PATIENTS WITH ADVANCED IMMUNODEFICIENCY

      AIDS
    61. LEFAUCHEUR JP; AUTHIER FJ; VERROUST J; GHERARDI RK
      ZIDOVUDINE AND HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED PERIPHERAL NEUROPATHIES - LOW INTAKE IN PATIENTS WITH MONONEUROPATHY MULTIPLEX AND NO EVIDENCE FOR NEUROTOXICITY

      Muscle & nerve
    62. REYNAUDMENDEL B; JANIER M; GERBAKA J; HAKIM C; RABIAN C; CHASTANG C; MOREL P
      DERMATOLOGICAL FINDINGS IN HIV-1-INFECTED PATIENTS - A PROSPECTIVE-STUDY WITH EMPHASIS ON CD4+ CELL COUNT

      Dermatology
    63. SCHNEIDER MME; SPRENGER MJW; HOEPELMAN IM; VANDERGRAAF Y; BORLEFFS JCC
      ANTIBODY-RESPONSE TO TETRAVALENT INFLUENZA SUBUNIT VACCINE IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      International journal of antimicrobial agents
    64. GRAHAM NMH
      THE ROLE OF IMMUNOLOGICAL AND VIRAL MARKERS IN PREDICTING CLINICAL OUTCOME IN HIV-INFECTION

      AIDS
    65. SATTEN GA; LONGINI IM
      MARKOV-CHAINS WITH MEASUREMENT ERROR - ESTIMATING THE TRUE COURSE OF A MARKER OF THE PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE

      Applied Statistics
    66. KAZEMPOUR K; KAMMERMAN LA; FARR SS
      SURVIVAL EFFECTS OF ZDV, DDI, AND DDC IN PATIENTS WITH CD4-LESS-THAN-OR-EQUAL-TO-50 CELLS MM(3)/

      Journal of acquired immune deficiency syndromes and human retrovirology
    67. LAUDAT A; ANOMONFILS N; PILEIRE B
      PLASMA FIBRONECTIN LEVELS AND CD4-INFECTED PATIENTS( LYMPHOCYTE COUNTS IN HIV)

      Medical science research
    68. HAMILTON AS; RADKA SF; BERNSTEIN L; GILL PS; GONSALVES M; NAEMURA JR; ROSS RK
      RELATIONSHIP OF SERUM LEVELS OF ONCOSTATIN-M TO AIDS-RELATED AND CLASSIC KAPOSIS-SARCOMA

      Journal of acquired immune deficiency syndromes
    69. VOLBERDING PA; GRAHAM NMH
      INITIATION OF ANTIRETROVIRAL THERAPY IN HIV-INFECTION - A REVIEW OF INTERSTUDY CONSISTENCIES

      Journal of acquired immune deficiency syndromes
    70. BROUSSET P; DROUET E; SCHLAIFER D; ICART J; PAYEN C; MEGGETTO F; MARCHOU B; MASSIP P; DELSOL G
      EPSTEIN-BARR-VIRUS (EBV) REPLICATIVE GENE-EXPRESSION IN TUMOR-CELLS OF AIDS-RELATED NON-HODGKINS-LYMPHOMA IN RELATION TO CD4 CELL NUMBER AND ANTIBODY-TITERS TO EBV

      AIDS
    71. SATTEN GA; LONGINI IM
      ESTIMATION OF INCIDENCE OF HIV-INFECTION USING CROSS-SECTIONAL MARKERSURVEYS

      Biometrics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 04:54:53